Literature DB >> 18794294

Important role for Toll-like receptor 9 in host defense against meningococcal sepsis.

Hong Sjölinder1, Trine H Mogensen, Mogens Kilian, Ann-Beth Jonsson, Søren R Paludan.   

Abstract

Neisseria meningitidis is a leading cause of meningitis and sepsis. The pathogenesis of meningococcal disease is determined by both bacterial virulence factors and the host inflammatory response. Toll-like receptors (TLRs) are prominent activators of the inflammatory response, and TLR2, -4, and -9 have been reported to be involved in the host response to N. meningitidis. While TLR4 has been suggested to play an important role in early containment of infection, the roles of TLR2 and TLR9 in meningococcal disease are not well described. Using a model for meningococcal sepsis, we report that TLR9(-/-) mice displayed reduced survival and elevated levels of bacteremia compared to wild-type mice. In contrast, TLR2(-/-) mice controlled the infection in a manner comparable to that of wild-type mice. TLR9 deficiency was also associated with reduced bactericidal activity in vitro, which was accompanied by reduced production of nitric oxide by TLR9-deficient macrophages. Interestingly, TLR9(-/-) mice recruited more macrophages to the bloodstream than wild-type mice and produced elevated levels of cytokines at late time points during infection. At the cellular level, activation of signal transduction and induction of cytokine gene expression were independent of TLR2 or TLR9 in macrophages and conventional dendritic cells. In contrast, plasmacytoid dendritic cells relied entirely on TLR9 to induce these activities. Thus, our data demonstrate an important role for TLR9 in host defense against N. meningitidis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18794294      PMCID: PMC2573357          DOI: 10.1128/IAI.00615-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Human toll-like receptor 4 mutations are associated with susceptibility to invasive meningococcal disease in infancy.

Authors:  Joerg Faber; Claudius U Meyer; Christina Gemmer; Alexandra Russo; Adam Finn; Craig Murdoch; Werner Zenz; Christine Mannhalter; Bernhard U Zabel; Heinz-J Schmitt; Pirmin Habermehl; Fred Zepp; Markus Knuf
Journal:  Pediatr Infect Dis J       Date:  2006-01       Impact factor: 2.129

2.  Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns.

Authors:  Trine H Mogensen; Søren R Paludan; Mogens Kilian; Lars Ostergaard
Journal:  J Leukoc Biol       Date:  2006-05-26       Impact factor: 4.962

3.  Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice.

Authors:  Cathy A Newton; Izabella Perkins; Raymond H Widen; Herman Friedman; Thomas W Klein
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

4.  Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection.

Authors:  Peter Bergman; Linda Johansson; Hong Wan; Allison Jones; Richard L Gallo; Gudmundur H Gudmundsson; Tomas Hökfelt; Ann-Beth Jonsson; Birgitta Agerberth
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

5.  Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection.

Authors:  Andre Bafica; Helton Costa Santiago; Romina Goldszmid; Catherine Ropert; Ricardo T Gazzinelli; Alan Sher
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

6.  MyD88-dependent signaling affects the development of meningococcal sepsis by nonlipooligosaccharide ligands.

Authors:  Laura Plant; Hong Wan; Ann-Beth Jonsson
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

7.  Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection.

Authors:  Barbara Albiger; Sofia Dahlberg; Andreas Sandgren; Florian Wartha; Katharina Beiter; Hiroaki Katsuragi; Shizuo Akira; Staffan Normark; Birgitta Henriques-Normark
Journal:  Cell Microbiol       Date:  2006-09-27       Impact factor: 3.715

8.  Two neisseria meningitidis strains with different ability to stimulate toll-like receptor 4 through the MyD88-independent pathway.

Authors:  T H Mogensen; S R Paludan; M Kilian; L Østergaard
Journal:  Scand J Immunol       Date:  2006-12       Impact factor: 3.487

9.  Imaging of disease dynamics during meningococcal sepsis.

Authors:  Hong Sjölinder; Ann-Beth Jonsson
Journal:  PLoS One       Date:  2007-02-21       Impact factor: 3.240

10.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

View more
  22 in total

1.  DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines.

Authors:  S E Sahingur; X-J Xia; S Alamgir; K Honma; A Sharma; H A Schenkein
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

Review 2.  Pathogen recognition and inflammatory signaling in innate immune defenses.

Authors:  Trine H Mogensen
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

3.  The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.

Authors:  Floris Fransen; Hendrik Jan Hamstra; Claire J Boog; Jos P van Putten; Germie P J M van den Dobbelsteen; Peter van der Ley
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

4.  A nonsynonymous polymorphism of IRAK4 associated with increased prevalence of gram-positive infection and decreased response to toll-like receptor ligands.

Authors:  Ainsley M Sutherland; Keith R Walley; Taka-Aki Nakada; Andy H P Sham; Mark M Wurfel; James A Russell
Journal:  J Innate Immun       Date:  2011-05-14       Impact factor: 7.349

5.  DNA Sensing in the Innate Immune Response.

Authors:  Benoit Briard; David E Place; Thirumala-Devi Kanneganti
Journal:  Physiology (Bethesda)       Date:  2020-03-01

6.  Importance of Toll-like receptor 9 in host defense against M1T1 group A Streptococcus infections.

Authors:  Annelies S Zinkernagel; Petr Hruz; Satoshi Uchiyama; Maren von Köckritz-Blickwede; Reto A Schuepbach; Tomoko Hayashi; Dennis A Carson; Victor Nizet
Journal:  J Innate Immun       Date:  2011-08-19       Impact factor: 7.349

7.  Cooperative interactions between TLR4 and TLR9 regulate interleukin 23 and 17 production in a murine model of gram negative bacterial pneumonia.

Authors:  Urvashi Bhan; Megan N Ballinger; Xianying Zeng; Michael J Newstead; Matthew D Cornicelli; Theodore J Standiford
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

8.  Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth.

Authors:  Stephen A Spector; Min Qin; Jorge Lujan-Zilbermann; Kumud K Singh; Meredith G Warshaw; Paige L Williams; Patrick Jean-Philippe; Terence Fenton; George K Siberry
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

9.  Toll-Like Receptor 9 Contributes to Defense against Acinetobacter baumannii Infection.

Authors:  Michael J Noto; Kelli L Boyd; William J Burns; Matthew G Varga; Richard M Peek; Eric P Skaar
Journal:  Infect Immun       Date:  2015-08-03       Impact factor: 3.441

10.  The Relationship Between Sepsis-induced Immunosuppression and Serum Toll-like Receptor 9 Level.

Authors:  Nazan Atalan; Leyla Acar; Nihan Yapici; Turkan Kudsioglu; Arzu Ergen; Seda Gulec Yilmaz; Turgay Isbir
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.